Company Comparison
Syros Pharmaceuticals vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Syros Pharmaceuticals | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Syros Pharmaceuticals
Clinical-stage biotech developing cancer treatments by controlling gene expression using proprietary gene control platforms.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Syros Pharmaceuticals and 10x Genomics operate in Biotech.
Browse all Biotech companies →